Anthranoid laxatives influence the absorption of poorly permeable drugs in human intestinal cell culture model (Caco-2)

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 66, Issue 1, 2007, Pages 135-145

  Laitinen, Leena ^a   Takala, Elina ^a   Vuorela, Heikki ^a   Vuorela, Pia ^a   Kaukonen, Ann Marie ^a   Marvola, Martti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Absorption of drugs; Anthranoid laxatives; Caco 2 permeability; Sennosides

Indexed keywords

DANTRON; DIGOXIN; FUROSEMIDE; KETOPROFEN; LAXATIVE; PARACETAMOL; PROPRANOLOL; RHEIN; RHODAMINE 123; SENNA EXTRACT; SENNIDIN; SENNIDIN A; SENNOSIDE A; SENNOSIDE B; UNCLASSIFIED DRUG; VERAPAMIL;

APICAL MEMBRANE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG FORMULATION; DRUG PENETRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE CELL; MONOLAYER CULTURE;

ABSORPTION; ACETAMINOPHEN; ANTHRAQUINONES; BEVERAGES; CACO-2 CELLS; CARBON RADIOISOTOPES; CATHARTICS; CELL MEMBRANE PERMEABILITY; DIGOXIN; FUROSEMIDE; HUMANS; KETOPROFEN; MANNITOL; PLANT LEAVES; PROPRANOLOL; SENNA EXTRACT; VERAPAMIL;

EID: 33947121637     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.09.006     Document Type: Article

References (41)

1. Franz G. The senna drug and its chemistry. Pharmacology 47 (1993) 2-6
2. de Witte P. Metabolism and pharmacokinetics of anthranoids. Pharmacology 47 (1993) 86-97
3. Lemli J. Metabolism of Sennosides - an overview. Pharmacology 36 (1988) 126-128
4. de Witte P., and Lemli J. The metabolism of anthranoid laxatives. Hepatogastroenterology 37 (1990) 601-605
5. Breimer D.D., and Baars A.J. Pharmacokinetics and metabolism of anthraquinone laxatives. Pharmacology 14 (1976) 30-47
6. Yagi T., Miyawaki Y., Nishikawa T., Yamauchi K., and Kuwano S. Involvement of prostaglandin-like material in the purgative action of rhein anthrone, the intraluminal active metabolite of sennosides A and B in mice. J. Pharm. Pharmacol. 40 (1988) 27-30
7. Nijs G., de Witte P., Geboes K., and Lemli J. Influence of rhein anthrone and rhein on small intestine transit rate in rats: evidence of prostaglandin mediation. Eur. J. Pharmacol. 218 (1992) 199-203
8. Leng-Peschlow E. Dual effect of orally administered sennosides on large intestine transit and fluid absorption in the rat. J. Pharm. Pharmacol. 38 (1986) 606-610
9. Beubler E., and Kollar G. Prostaglandin-mediated action of sennosides. Pharmacology 36 (1988) 85-91
10. van Hoestenberghe A., de Witte P., Geboes K., Eyssen H., Nijs G., and Lemli J. The effect of rhein and rhein anthrone on intestinal fluid transport and on large intestine transit in germfree rats. Eur. J. Pharmacol. 212 (1992) 121-123
11. +-ATPase and permeability in vitro. Pharmacology 36 (1988) 98-103
12. Ewe K. The physiological basis of laxative action. Pharmacology 20 (1980) 2-20
13. Nilsson D., Fagerholm U., and Lennernäs H. The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum. Pharm. Res. 11 (1994) 1540-1544
14. Artursson P. Epithelial transport of drugs I. A model for studying the transport of drugs (β-blocking agents) over an intestinal epithelial cell line (Caco-2). J. Pharm. Sci. 79 (1990) 476-482
15. Cogburn J.N., Donovan M.G., and Schaasteen C.S. A model of human small intestinal absorptive cells. 1. Transport barrier. Pharm. Res. 8 (1991) 210-216
16. Artursson P., Palm K., and Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 22 (1996) 67-84
17. Laitinen L., Kangas H., Kaukonen A.M., Hakala K., Kotiaho T., Kostiainen R., and Hirvonen J. N-in-one permeability studies of heterogeneous sets of compounds across Caco-2 cell monolayers. Pharm. Res. 20 (2003) 187-197
18. Bailey D.G., Malcolm J., Arnold O., and Spence J.D. Grapefruit juice-drug interactions. Br. J. Clin. Pharmacol. 46 (1998) 101-110
19. Laitinen L., Tammela P., Galkin A., Vuorela H., Marvola M., and Vuorela P. Effects of extracts of commonly consumed food supplements and food fractions on the permeability of drugs across Caco-2 cell monolayers. Pharm. Res. 21 (2004) 1904-1916
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
21. Ogihara T., Tamai I., Takanaga H., Sai Y., and Tsuji A. Stereoselective and carrier-mediated transport of monocarboxylic acids across Caco-2 cells. Pharm. Res. 13 (1996) 1828-1832
22. Choi J.-S., Jin M.J., and Han H.-K. Role of monocarboxylic acid transporters in the cellular uptake of NSAIDs. J. Pharm. Pharmacol. 57 (2005) 1185-1189
23. Avdeef A., Berger C.M., and Brownell C. pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharm. Res. 17 (2000) 85-89
24. Verhaeren E.H.C. Mitochondrial uncoupling activity as a possible base for a laxative and antiproriatic effect. Pharmacology 20 (1980) 43-49
25. Bruneton J. Pharmacognosy, Phytochemistry, Medicinal Plants (1995), Lavoisier Publishing, Paris, France
26. Müller B.M., Kraus J., and Franz G. Chemical structure and biological activity of water-soluble polysaccharides from Cassia angustifolia leaves. Planta Med. 55 (1989) 536-539
27. Yang J., Kim K.-J., and Lee V.H.L. Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers. Pharm. Res. 17 (2000) 533-538
28. Orlowski S., Mir J., Belehradek J., and Garrigos M. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem. J. 317 (1996) 515-522
29. van Gorgom B.A.P., Timmer-Bosscha H., de Jong S., van der Kolk D.M., Kleibeuker J.H., and deVries E.G.E. Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1. Br. J. Cancer 86 (2002) 1494-1500
30. Döppenschmitt S., Spahn-Langguth H., Regårdh C.G., and Langguth P. Role of P- glycoprotein-mediated secretion in absorptive drug permeability: an approach using passive membrane permeability and affinity to P-glycoprotein. J. Pharm. Sci. 88 (1999) 1067-1072
31. Polli J., Wring S., Humphreys J., Huang L., Morgan J., Webster L., and Serabjit-Singh C. Rational use of in vitro P-glycoprotein assays in drug discovery. J. Pharmacol. Exp. Ther. 299 (2001) 620-628
32. Collett A., Tanianis-Hughes J., and Warhurst G. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?. Biochem. Pharmacol. 68 (2004) 783-790
33. Pade V., and Stavchansky S. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm. Res. 14 (1997) 1210-1215
34. Flanagan S.D., Takahashi L.H., Liu X., and Benet L.Z. Contributions of saturable active secretion, passive transcellular, and paracellular diffusion to the overall transport of furosemide across adenocarcinoma (Caco-2) cells. J. Pharm. Sci. 91 (2002) 1169-1177
35. Flanagan S.D., Cummins C.L., Susanto M., Liu X., Takahashi L.H., and Benet L.Z. Comparison of furosemide and vinblastine secretion from cell lines overexpressing multidrug resistance protein (P-glycoprotein) and multidrug resistance-associated proteins (MRP1 and MRP2). Pharmacology 64 (2002) 126-134
36. Troutman M.D., and Thakker D.R. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells. Pharm. Res. 20 (2003) 1192-1199
37. Cavet M.E., West M., and Simmons N.L. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 118 (1996) 1389-1396
38. Lowes S., Cavet M.E., and Simmons N.L. Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers. Eur. J. Pharmacol. 458 (2003) 49-56
39. van Dijk C., Driessen A.J.M., and Recour K. The uncoupling efficiency and affinity of flavonoids for vesicles. Biochem. Pharmacol. 60 (2000) 1593-1600
40. Tammela P., Laitinen L., Galkin A., Wennberg T., Heczko R., Vuorela H., Slotte J.P., and Vuorela P. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles. Arch. Biochim. Biophys. 425 (2004) 193-199
41. Leng-Peschlow E. Sennoside-induced secretion and its relevance for the laxative effect. Pharmacology 47 (1993) 14-21